Tci Wealth Advisors, Inc. Organogenesis Holdings Inc. Transaction History

Tci Wealth Advisors, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 29, 2022	SELL	$6.47 - $9.57 $2,730 - $4,038	-422 Closed	0 $0
Q4 2021 Jan 24, 2022	BUY	$9.02 - $13.5 $3,806 - $5,697	422 New	422 $4,000
Q3 2020 Oct 20, 2020	SELL	$3.29 - $4.58 $329 - $458	-100 Closed	0 $0
Q2 2020 Jul 20, 2020	BUY	$2.86 - $4.61 $286 - $461	100 New	100 $0
Q4 2019 Jan 27, 2020	SELL	$4.7 - $8.11 $460 - $794	-98 Closed	0 $0
Q3 2019 Oct 17, 2019	BUY	$3.57 - $8.09 $349 - $792	98 New	98 $1,000

117

63.2M

25K

23.2K

Ticker ORGO
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 130,888,000
Market Cap $408M
Description
Organogenesis Holdings Inc., a regenerative medicine company develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States. The company's advanced wound care products include Affinity, an amniotic membrane wound covering in which viable cells growth factors/cytokin...

Get notified when there are updates to the investment portfolio of Tci Wealth Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Tci Wealth Advisors, Inc. with notifications on news.